# TG Therapeutics, Inc.: Form 8-K, filed Feb 28, 2024

- Company: [TG Therapeutics, Inc.](/companies/tgtx.md) (CIK 1001316)
- Form: 8-K
- Filed: 2024-02-28
- Accepted by EDGAR: Feb 28, 2024, 07:24 ET
- Period: 2024-02-28
- Accession: 0001437749-24-005802
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1001316/000143774924005802/tgtx20240227_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1001316/000143774924005802/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1001316/000143774924005802/tgtx20240227_8k.htm

Filed Feb 28, 2024.
Source: SEC EDGAR, the filing index for accession 0001437749-24-005802. Last ingested by Listed: Oct 24, 2026, 15:01 ET. No prices; not investment advice.